615 filings
8-K
REGN
Regeneron Pharmaceuticals, Inc.
2 May 24
Regeneron Reports First Quarter 2024 Financial and Operating Results
7:06am
ARS
2023 FY
REGN
Regeneron Pharmaceuticals, Inc.
25 Apr 24
Annual report to shareholders
4:09pm
DEFA14A
REGN
Regeneron Pharmaceuticals, Inc.
25 Apr 24
Additional proxy soliciting materials
4:02pm
DEF 14A
REGN
Regeneron Pharmaceuticals, Inc.
Definitive proxy
25 Apr 24
4:01pm
8-K
hizc9i s9i0vfm3pb0k4
2 Feb 24
Regeneron Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
7:16am
8-K
ihooqo5s1f
31 Jan 24
Departure of Directors or Certain Officers
4:17pm
8-K
i1rsy ojhuyae
8 Jan 24
2 Strategy & Business Update J.P.Morgan Healthcare Conference 2024 Co - Founder, Board Co - Chair, President & Chief Executive Officer
6:30am
8-K
mjxbch1ur8 wz
2 Nov 23
Regeneron Reports Third Quarter 2023 Financial and Operating Results
7:10am
8-K
abmxo4d
5 Oct 23
Results of Operations and Financial Condition
4:04pm
SC TO-T/A
7pl2i2hddj
25 Sep 23
Third party tender offer statement (amended)
8:48am
SC TO-T/A
ewssgyl
12 Sep 23
Third party tender offer statement (amended)
4:38pm
8-K/A
my794tos94a or
8 Sep 23
Submission of Matters to a Vote of Security Holders
5:00pm
8-K
6ocro7l wuy
8 Sep 23
Departure of Directors or Certain Officers
4:52pm
SC TO-T/A
72v swp11uf8
8 Sep 23
Third party tender offer statement (amended)
4:05pm
SC TO-T
aab38q1
25 Aug 23
Third party tender offer statement
7:46am
SC TO-C
gkuw725mn nm6
9 Aug 23
Information about tender offer
4:15pm